Abstract

Abstract The unfolded protein response (UPR), a multi-faceted signaling system emanating from the endoplasmic reticulum (ER) membrane, plays a critical role in the differentiation of B-lymphocytes into antibody-secreting plasma cells. Specifically, XBP1(S), a UPR transcriptional activator generated by IRE1-mediated splicing of Xbp1(u) mRNA, mediates expansion of the ER, up-regulates expression of many secretory pathway genes, and is required for normal antibody production. However, a full understanding of the molecular mechanisms regulating expression of Xbp1 is still lacking. Using bioinformatics analysis, we identified a microRNA (miR-30c-2*) predicted to target Xbp1 mRNA. Indeed, luciferase reporter assays demonstrated that miR-30c-2* targets a site in the 3’-untranslated region of Xbp1 mRNA in a sequence-specific manner. Over-expression of miR-30c-2* attenuated expression of both Xbp1 and XBP1(S) target genes, consistent with diminished expression of XBP1(S) protein. Furthermore, our studies revealed that expression of miR-30c-2* is up-regulated during UPR activation, concomitant with Xbp1, suggesting a feedback mechanism for XBP1(S) homeostasis. Finally, preliminary studies provided evidence linking expression of miR-30c-2* with specific UPR signaling events. These data provide the first link between microRNA and the UPR and, importantly, implicate miR-30c-2* in the regulation of Xbp1 and plasma cell differentiation.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.